Gibson Capital LLC acquired a new stake in shares of Vanguard Intermediate-Term Bond ETF (NYSEARCA:BIV – Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 4,360 shares of the company’s stock, valued at approximately $342,000.
Other hedge funds also recently bought and sold shares of the company. WNY Asset Management LLC purchased a new stake in shares of Vanguard Intermediate-Term Bond ETF in the fourth quarter worth approximately $229,000. Centaurus Financial Inc. purchased a new stake in shares of Vanguard Intermediate-Term Bond ETF in the fourth quarter worth approximately $1,316,000. Slagle Financial LLC lifted its position in shares of Vanguard Intermediate-Term Bond ETF by 56.7% in the fourth quarter. Slagle Financial LLC now owns 5,934 shares of the company’s stock worth $453,000 after purchasing an additional 2,147 shares in the last quarter. Fisher Asset Management LLC purchased a new stake in shares of Vanguard Intermediate-Term Bond ETF in the fourth quarter worth approximately $322,000. Finally, Trust Co. of Vermont lifted its position in shares of Vanguard Intermediate-Term Bond ETF by 2.2% in the fourth quarter. Trust Co. of Vermont now owns 13,304 shares of the company’s stock worth $1,016,000 after purchasing an additional 284 shares in the last quarter.
Vanguard Intermediate-Term Bond ETF Price Performance
NYSEARCA BIV opened at $76.93 on Friday. The company has a 50 day simple moving average of $77.83 and a 200-day simple moving average of $75.81. Vanguard Intermediate-Term Bond ETF has a 52-week low of $70.43 and a 52-week high of $78.89.
Vanguard Intermediate-Term Bond ETF Profile
Vanguard Intermediate-Term Bond ETF (the Fund) seeks to track the performance of a market-weighted bond index with an intermediate-term, dollar-weighted average maturity. The Fund employs a passive management or indexing strategy designed to track the performance of the Barclays Capital U.S. 5-10 Year Government/Credit Bond Index (the Index).
See Also
- Five stocks we like better than Vanguard Intermediate-Term Bond ETF
- Top Biotech Stocks: Exploring Innovation Opportunities
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- What is the Nasdaq? Complete Overview with History
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- Using the MarketBeat Stock Split Calculator
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Want to see what other hedge funds are holding BIV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vanguard Intermediate-Term Bond ETF (NYSEARCA:BIV – Free Report).
Receive News & Ratings for Vanguard Intermediate-Term Bond ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vanguard Intermediate-Term Bond ETF and related companies with MarketBeat.com's FREE daily email newsletter.